Evolent Appoints Archie Mayani as Chief Product Officer
5 min read
Evolent Health (NYSE: EVH), the specialty care management company focused on improving outcomes for people with complex conditions, has appointed Archie Mayani as its new Chief Product Officer. The appointment brings to Evolent a leader with more than two decades of experience across healthcare technology, enterprise platforms, and AI — with a CV that spans GHX, Change Healthcare, Optum, UnitedHealth Group, and Amazon Prime Video. It is a hire calibrated for a specific moment: a period in which AI is creating genuine, consequential opportunities to redesign the economics and outcomes of specialty healthcare, and in which the organisations best positioned to capitalise on those opportunities are those with the proprietary clinical data, trusted payer and provider relationships, and product execution capability to translate AI potential into clinical reality at scale.
A Career Built at the Intersection of Healthcare Complexity and Technology Scale
Mayani's career is a distinctive combination of two experiences that are rarely found together in the same executive: deep fluency in the operational and clinical complexity of the US healthcare system, and proven product leadership at technology platforms operating at consumer internet scale. Both halves of that background are directly relevant to Evolent's current strategic priorities.
Most recently, she served as Chief Product Officer at GHX — the global healthcare supply chain exchange — where she pioneered AI-powered capabilities designed to strengthen the resilience of health system procurement and supply chain operations. Before GHX, she held the CPO role at Change Healthcare, where she led products across clinical decision support, enterprise imaging, and revenue cycle platforms — driving innovations specifically aimed at reducing administrative burden in prior authorisation for both providers and payers. That particular focus — the friction-intensive, clinically consequential process of prior authorisation — is directly aligned with Evolent's own product strategy in specialty care management, making her experience at Change Healthcare among the most directly applicable elements of her background.
Earlier in her career, leadership roles at Optum and UnitedHealth Group gave her formative experience in scaling value-based care through population health and preventive care programmes — work that delivered measurable improvements in customer satisfaction, raised Medicare STARS performance, and reduced avoidable hospital and emergency department utilisation. These are exactly the outcome metrics that define success in specialty care management, and experience in achieving them at the scale of one of the largest healthcare organisations in the world represents a depth of operational fluency that few product leaders in the sector possess.
Alongside her healthcare career, Mayani served as Global Head of Product and Content Operations for Amazon Prime Video during a period of significant catalogue growth — transforming operations with machine-learning-based optimisation at a scale and velocity that is genuinely unusual in a healthcare executive's background. That experience — building product at the intersection of content intelligence, personalisation, and operational efficiency for a platform serving hundreds of millions of users — provides a grounding in what AI-driven product execution looks like when it operates at consumer internet scale, bringing a different kind of technical ambition to the healthcare-specific challenges she now inherits at Evolent.
"We are thrilled to have Archie on board to accelerate Evolent's product strategy. Her deep knowledge of value-based care, health tech and prior authorization, combined with her impressive track record of delivering innovation and AI transformation at scale, made her an ideal hire to drive best-in-class performance for our products and platforms."
— Dan McCarthy, President, Evolent
The Strategic Context: AI, Proprietary Data, and the Specialty Care Opportunity
Evolent's core business is specialty care management — helping health plans and providers manage the clinical and financial complexity of high-cost, high-acuity patient populations across oncology, musculoskeletal care, cardiology, and other specialty areas. The company operates at a structural intersection that is particularly well-positioned for AI-driven value creation: it holds large proprietary clinical datasets spanning authorisations, clinical decisions, and outcomes across a broad population, it sits between payers and providers as a trusted intermediary, and it manages processes — prior authorisation chief among them — where AI-driven automation and clinical intelligence have the clearest, most measurable potential to reduce administrative burden, accelerate access to care, and improve clinical decision quality simultaneously.
Prior authorisation is worth calling out specifically because it represents one of the most economically and clinically consequential administrative processes in the US healthcare system. Physicians and clinical staff collectively spend billions of hours annually navigating PA requirements across health plans — delaying care, generating friction, and in some cases leading to adverse outcomes when treatment is withheld pending approval. AI-driven clinical decision support that can accelerate PA decisions, reduce inappropriate denials, and surface evidence-based clinical criteria in real time for both providers submitting authorisations and payers reviewing them has been one of the most sought-after capabilities in healthcare technology for the past several years. Mayani's specific CPO experience at Change Healthcare — where she led PA-related product innovation — makes her directly and unusually equipped to drive this agenda at Evolent.
"This is a crucial opportunity at a time when AI is fundamentally reshaping health care. Evolent has the foundation, the mission, and the trust to lead. I am excited to help bring our products, our enormous proprietary datasets, and AI together to create smarter experiences and greater value across the health care ecosystem."
— Archie Mayani, Chief Product Officer, Evolent
Industry Recognition and Responsible AI Leadership
Mayani's industry profile extends beyond executive appointments. She has received several notable honours, including the Inspiring Leader Award at the Health 2.0 conference (2023), recognition as one of the Top 50 Women Leaders of San Francisco (2023), and the Global CPO Award Winner by Products that Count (2025). She is a frequent speaker on responsible AI, product innovation, and the future of healthcare — a public profile that reflects an orientation toward the governance and ethical dimensions of AI deployment in clinical settings, not only its commercial potential.
That emphasis on responsible AI is particularly relevant in the healthcare context, where the consequences of AI errors — inappropriate care denials, missed clinical indicators, biased algorithmic decision-making — are not abstract quality problems but clinical harms with direct patient impact. Building AI-powered products that clinicians and health plans will trust requires not only technical capability but a demonstrated commitment to the responsible use of data and models in settings where that trust is both earned slowly and essential to adoption. Mayani's track record as a speaker and thought leader on these questions is a signal that Evolent is approaching its AI product investment with the governance seriousness that the clinical context demands. Explore the latest Artificial Intelligence News for more updates across AI, healthtech, and enterprise technology.
Key Takeaways
- Evolent Health (NYSE: EVH) has appointed Archie Mayani as Chief Product Officer — bringing 20+ years of healthcare technology and AI leadership from GHX, Change Healthcare, Optum, UnitedHealth Group, and Amazon Prime Video.
- Her prior authorisation product leadership at Change Healthcare — reducing administrative burden across clinical decision support, enterprise imaging, and revenue cycle platforms — is directly aligned with Evolent's core specialty care management proposition.
- Value-based care scaling experience at Optum and UnitedHealth Group produced measurable Medicare STARS improvements and reductions in avoidable hospital and ED utilisation — outcomes that directly define success in Evolent's specialty care business.
- Amazon Prime Video experience in ML-based content operations at consumer internet scale brings a different dimension of technical ambition — and a proof point for AI-driven product transformation — to Mayani's healthcare-native background.
- The appointment signals Evolent's intent to combine its large proprietary clinical datasets with AI-driven product innovation across specialty care management — with a CPO who has explicit public track record on both responsible AI governance and delivering AI transformation at operational scale.